Chronic Low Back Pain Market Overview, SWOT Analysis and Forecast...

added article Other

2021-12-23 06:30:22 -

Chronic Low Back Pain Market Overview, SWOT Analysis and Forecast to 2030

In terms of revenue, the global chronic low back pain market stood at US$ 6429.30 Mn in 2018 and is anticipated to reach US$ 10012.52 Mn by 2027, expanding at a CAGR of 4.8% over the next eight years. Key players operating in the global chronic low back pain market are Astellas Pharma Inc., Grunenthal GmbH, Orion Oyj, Pfizer Inc., Regeneron Pharmaceuticals, Inc, Array BioPharma Inc., Egale...

0 Comments 0 Shares 2249 Views 0 Reviews